Peer Review Policy & Process

Pharmaceutical Communications is using an online article submission, review, and tracking system for quality and quick review processing.  The journal provides a rapid review process of approx. 04-06 weeks followed by the publication of research articles.


The editorial board members of Pharmaceutical Communications in connection with the Editor-In-Chief are bound with ethical and honest accountability to support the researchers and interested individuals. Journal provides a wide platform with humane support to newer researchers and creative individuals in the field of pharmaceutics.


Manuscripts submitted to Pharmaceutical Communications are subjected to single-blind peer review and are therefore expected to be of high quality. Manuscripts submitted for publication consideration must have the ability to contribute to the field of pharmaceutical sciences. This contribution may be small but meaningful and forms the rubric of what our reviewers and editors look for during the review process. The journal applies a very rigorous review process in determining which articles are accepted and eventually published. We strive for a rapid review and subsequent publication of high-quality manuscripts.


After preliminary checking by the handling editor, the submitted article is first reviewed by the Editor-In-Chief, who examines the manuscript and decides on its acceptance followed by a peer review by at least two subject experts through a single-blind review process. The corresponding author is informed through e-mail about the editorial decision as soon as possible. The rejected article is always supported for a newer submission.


The revision should also be accompanied by a point-by-point response to referees explaining how the manuscript has been changed. The manuscript may then be sent back to the original referees or new referees.


When all editorial issues are resolved, the manuscript is formally accepted for publication. After acceptance, authors are sent proofs of their manuscript, but only typo mistakes are permitted to be corrected. All corrections are approved by the production team. The journal reserves the right to make the final decision about matters of style and the size of figures.


Pharmaceutical Communications does not guarantee manuscript acceptance or very short peer review.